C.I. Medical Co.,Ltd.
3540.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.77 | -0.59 | 0.16 | -0.15 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | 55.25 | 25.59 | 18.34 | 32.00 |
| Quality | ||||
| ROIC | 2.19% | 2.72% | 1.27% | 2.37% |
| Gross Margin | 35.81% | 35.57% | 33.88% | 35.45% |
| Cash Conversion Ratio | – | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | 26.56% | 26.49% | 33.42% | 45.46% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.53 | 0.81 | 1.91 | 8.67 |
| Interest Coverage | 54.36 | 109.08 | 19.16 | 60.22 |
| Efficiency | ||||
| Inventory Turnover | 0.96 | 0.99 | 0.99 | 0.92 |
| Cash Conversion Cycle | 76.78 | 74.32 | 80.02 | 80.90 |